CD44, a cancer stem cell (CSC)-related surface marker, correlates with local control after radiotherapy of early laryngeal cancer. For the first time, a CSC-related marker has been functionally validated for radiotherapy in patients. CD44 expression bears the potential to predict the outcome of radiotherapy by assessment of CSC density.
No takes yet. Share an insight, caveat, or question.
Baumann et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: